Table 4 Correlation of odor identification scores with neuropsychological test results and CSF biomarker levels in selected categories of the A/T/N classification (A−/T−/N−, A+/T−/N−, A+/T+/N−, and A+/T+/N+), both in the presence and absence of ApoE4.

From: Odor identification score as an alternative method for early identification of amyloidogenesis in Alzheimer’s disease

 

Total

ApoE4(+)

ApoE4(−)

rho

P-value

rho

P-value

rho

P-value

Neuropsychological Test

 MMSE

0.517

 < 0.0001

0.258

0.194

0.425

0.0019

 ADAS-cog J

 − 0.551

< 0.0001

 − 0.222

0.267

− 0.468

0.0006

 FAB

0.509

< 0.0001

0.001

0.996

0.584

< 0.0001

 GDS

 − 0.014

0.907

0.052

0.798

− 0.035

0.809

 WMS-R Attention/Concentration score

0.381

0.001

0.175

0.404

0.467

0.0007

 WMS-R Delayed recall score

0.576

< 0.0001

0.259

0.212

0.526

0.0001

 WMS-R Logical Memory II score

0.578

< 0.0001

0.386

0.047

0.464

0.0008

CSF biomarkers

 Aβ40

0.027

0.8132

0.020

0.922

 − 0.006

0.9685

 Aβ42

0.386

0.0005

0.216

0.280

0.252

0.0739

 Aβ42/40 ratio

0.425

0.0001

0.305

0.122

0.317

0.0235

 p-Tau

 − 0.373

0.0008

 − 0.387

0.046

 − 0.143

0.3172

 t-Tau

 − 0.229

0.0435

 − 0.285

0.150

 − 0.088

0.5416

 p-Tau /Aβ42 ratio

 − 0.432

< 0.0001

 − 0.418

0.030

 − 0.250

0.0775

 p-Tau/t-Tau ratio

 − 0.129

0.2615

 − 0.152

0.450

 − 0.021

0.885

  1. Significant correlations were found between odor identification scores and the main neuropsychological tests (MMSE, ADAS-cog J, FAB, Attention/Concentration, Delayed recall, and Logical memory II) using Spearman rank correlation and between olfactory performance and CSF markers (Aβ42, Aβ42/40 ratio, p-Tau, t-Tau, and p-Tau/Aβ42).
  2. A (+) amyloid-positive individuals with A/T/N classification; A (−) amyloid-negative; T (+) p-Tau positive; T (−) p-Tau negative; N (+) t-Tau positive; N (−) t-Tau negative; AUC area under the curve; CSF cerebrospinal fluid; MMSE Mini-Mental State Examination; WMS-R Wechsler Memory Scale-revised; ADAS-cog J Alzheimer-Disease Assessment Scale-Cognitive-Japanese version.
  3. Significant values are in [bold].